 Growth asthmatic children treatment budesonide double blind trial OBJECTIVE inhaled glucocorticosteroid budesonide adverse effect short term linear growth children mild asthma SETTING Outpatient clinic secondary referral centre PATIENTS children years normal statural growth velocity previous year signs puberty use systemic topical steroids months study DESIGN OF INTERVENTIONS Double blind crossover trial active periods budesonide divided daily doses micrograms micrograms run washout periods placebo second washout period children open treatment micrograms budesonide periods days duration MAIN OUTCOME MEASURE Growth leg week knemometry RESULTS Mean growth velocity leg mm/week washout mm/week Budesonide treatment significant dose reduction growth velocity mean reduction growth velocity treatment confidence interval mm/week micrograms Page test treatment micrograms reduction mm/week CONCLUSIONS Treatment inhaled budesonide dose related suppression short term linear growth children mild asthma